Everett Mason, DPM
Podiatrist · Newnan, GANPI 1972535235
Payments from drug & device makers
What this record shows
This record is dominated by other: $14,560 of the $14,732 with a category attached, or 98.8%. Convatec Inc. accounts for 98.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $14,599 and has fallen 99.7% since, to $40 in 2025. Among podiatrist clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $1473.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$15K
- Johnson & Johnson$46
- Averitas Pharma Inc.$40
- BD$39
- Organogenesis Inc.$17
- Cardiva Medical, Inc.$17
- plus $13 from 1 others
What the payments were for
- Food & beverage$1721%
- Other$14,56099%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 1 | $14,560 |
| Johnson & Johnson | 3 | $46 |
| Averitas Pharma Inc. | 1 | $40 |
| BD | 2 | $39 |
| Organogenesis Inc. | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$14,560
How this compares
$14,732 in reported general payments places this provider in the 90th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 89 | $966 |
| Ketoconazole | 20 | $194 |
| Silver Sulfadiazine | 15 | $64 |
| Cephalexin | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Newnan
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
- Christopher CorwinJohns Creek$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.